We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Organogenesis Holdings
ORGO
$327M
| $79.3K | ﹤0.01% |
+15,311
| New | +$74.2K |
|
|
AIRJ
2702
Montana Technologies Corp
AIRJ
$295M
| $79.2K | ﹤0.01% |
+20,099
| New | +$86.8K |
|
2703
Hyperfine
HYPR
$91.3M
| $79.1K | ﹤0.01% |
80,735
+26,165
| +48% | +$31.6K |
|
2704
StealthGas
GASS
$328M
| $78.5K | ﹤0.01% |
+11,183
| New | +$75.1K |
|
2705
Cato Corp
CATO
$66.5M
| $78.3K | ﹤0.01% |
+25,331
| New | +$93.1K |
|
2706
UNIFI
UFI
$117M
| $78.3K | ﹤0.01% |
+22,359
| New | +$86.4K |
|
2707
Flexible Solutions
FSI
$64.4M
| $78.1K | ﹤0.01% |
+11,611
| New | +$91.7K |
|
2708
LivePerson
LPSN
$22.6M
| $77.9K | ﹤0.01% |
20,123
+13,133
| +188% | +$73.1K |
|
2709
Estrella Immunopharma
ESLA
$32.9M
| $77.2K | ﹤0.01% |
49,472
+39,099
| +377% | +$74K |
|
|
PPT
2710
Franklin Premier Income Trust
PPT
$323M
| $77.2K | ﹤0.01% |
+21,798
| New | +$78.6K |
|
2711
Lotus Technology
LOT
$551M
| $77.1K | ﹤0.01% |
54,711
+9,605
| +21% | +$15.3K |
|
|
SGMO
2712
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $77.1K | ﹤0.01% |
+183,531
| New | +$97.3K |
|
2713
Quantum Corp
QMCO
$441M
| $77.1K | ﹤0.01% |
+11,948
| New | +$107K |
|
2714
Sensus Healthcare
SRTS
$46.9M
| $76.8K | ﹤0.01% |
+19,299
| New | +$71.5K |
|
2715
Alpha Teknova
TKNO
$269M
| $76.5K | ﹤0.01% |
+20,142
| New | +$98K |
|
|
PUSA
2716
Aureus Greenway Holdings
PUSA
$61.1M
| $76.3K | ﹤0.01% |
+24,210
| New | +$113K |
|
|
AEC
2717
Anfield Energy
AEC
$79M
| $76.1K | ﹤0.01% |
+14,827
| New | +$105K |
|
2718
Perfect Corp
PERF
$197M
| $75.9K | ﹤0.01% |
41,914
-17,738
| -30% | -$33K |
|
|
CURR
2719
Currenc Group
CURR
$342M
| $75.4K | ﹤0.01% |
42,104
+16,821
| +67% | +$37.7K |
|
2720
Tenaya Therapeutics
TNYA
$162M
| $75.2K | ﹤0.01% |
105,692
+7,854
| +8% | +$10.7K |
|
2721
Blink Charging
BLNK
$68.2M
| $74.6K | ﹤0.01% |
111,779
-300,506
| -73% | -$435K |
|
|
GBIO
2722
DELISTED
Generation Bio
GBIO
| $74.5K | ﹤0.01% |
13,122
+1,778
| +16% | +$10K |
|
|
INTJ
2723
Intelligent Group
INTJ
$5.07M
| $74.5K | ﹤0.01% |
+6,206
| New | +$67.2K |
|
|
IGD
2724
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$512M
| $74.4K | ﹤0.01% |
+13,010
| New | +$75.4K |
|
2725
E.W. Scripps
SSP
$271M
| $74.3K | ﹤0.01% |
18,620
-146,090
| -89% | -$492K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.